Our site is optimized for screen resolutions of 1024 x 768 and higher. We’ve detected yours is set below this. For the best experience, please adjust your resolution. To close this message click here

How Can We Help?

In The News

Talking Buffalo Biomed with Randy Clower of Phillips Lytle  More

Randolph V. Clower Interviewed by The Metropolitan Corporate Counsel  More

Randolph V. Clower Comment on Decisions Involved in Starting a Business  More

View all for this attorney

Press Releases

Randolph V. Clower to Give Special Alumnus Talk for Pre-Law and Science Students at SUNY Fredonia  More

Randolph V. Clower to Participate on Panel at MedTech 2015 Conference  More

Dr. Randolph V. Clower Addressed the Buffalo World Trade Association on Protecting Intellectual Property Rights  More

View all for this attorney

Speaking Engagements

Speaker, Alumnus Talk for Pre-Law and Science, SUNY Fredonia, November 2015  More

Panelist, “Strategy & Development Track: Establishing a Roadmap for Your Bio Start Up,” MedTech 2015 Conference, October 2015  More

Speaker, “Protecting Your IPR (intellectual property rights) Internationally,” Buffalo World Trade Association Meeting, February 2015  More

View all for this attorney


Author, “Top 5 Post AIA Implementation University Considerations,” IPWatchdog, June 2013  More

Author, “Impending Myriad Decision Portends Promethean Consequences For Biotech Industry,” The Metropolitan Corporate Counsel, March 2013  More

Author, “Are Human Genes Patentable?” Phillips Lytle Intellectual Property Client Alert, December 2012  More

View all for this attorney

Randolph V. Clower, Ph.D., J.D.
Special Counsel - Life Sciences, Buffalo
(716) 847-5421

Dr. Clower leads the Biomedical & Life Sciences Patent Prosecution practice at Phillips Lytle. In concert with worldwide patent procurement, including prosecuting and preparing patent applications in all biomedical and related fields, Dr. Clower focuses his practice on the identification and exploitation of key intellectual property (IP) assets within various biotechnology product platforms. By outlining clear and practical strategies for leveraging product portfolio resources, Dr. Clower imparts practical strategies for increasing company stakeholder value while strengthening market presence.

Dr. Clower’s practice also includes counseling clients with respect to multi-party technology platform coalitions, where he routinely engages in due diligence assessments for parties on both sides of an asset purchase or acquisition. In addition to vetting global IP portfolios, Dr. Clower possesses particular proficiency in facilitating biotechnical, corporate-based, transactions from inception to close, while also possessing broad expertise associated with the technology transfer of proprietary innovations for various business entities.

Dr. Clower provides legal counsel with respect to domestic and international business development and commercialization matters – from concept-stage technologies throughout product development and maturation – where he provides legal advice concerning all forms of transactions involving intellectual property, e.g., license and commercial agreement drafting and review, assessing and preparing technology landscape overviews, non-infringement/invalidity opinions, freedom-to-operate (FTO) assessments, and patentability evaluations for individual inventors, university clients, small biotechnology companies, and FORTUNE® 500 clients.

Prior to joining Phillips Lytle, Dr. Clower was an intellectual property attorney at Foley & Lardner, LLP and LeClairRyan, PC. He also previously assisted the University at Buffalo Office of Science, Technology Transfer and Economic Outreach (STOR) in drafting patentability assessments.

Frequently engaged with the scientific community, Dr. Clower volunteers as intellectual property counsel for the local pre-seed workshops and business plan competitions. He also lectures on the changing landscape of U.S. and international patent law. Dr. Clower has been a “featured author” on JD Supra, and has drafted articles and comments for IPWatchdog.com, Law 360, Buffalo Niagara Enterprise, the Journal of Virology and Virology.

Dr. Clower is involved with the medical device and regulatory communities by sitting on the advisory board of a medical manufacturing and FDA regulatory compliance company, while additionally serving as an IP mentor for various start-up funding initiatives.

Dr. Clower served as a graduate research fellow during law school, where he was the recipient of the 2009 ABA and BNA Award for Excellence in the study of IP law and the 2008 Harold A. Dautch Memorial Scholarship. Dr. Clower received his doctorate in microbiology and immunology, and was the recipient of the NIH Pre-Doctorate Training Grant Fellowship for microbial pathogenesis during his graduate education. He earned his bachelors degree in recombinant gene technology while also obtaining a minor in chemistry.


  • Up & Coming Attorney, The Daily Record, 2016


State University of New York at Buffalo Law School, J.D., cum laude, 2009
State University of New York at Buffalo School of Medicine and Biomedical Sciences, Ph.D., 2006
State University of New York at Fredonia, B.S., summa cum laude, 2001


New York
U.S. Patent and Trademark Office - Registered Patent Attorney
Ontario, Canada - Foreign Legal Consultant


  • MakerStaker Mentor Program, Intellectual Property Mentor